Francois Binette

Francois Binette is the Managing Director and President at Renovaro Biosciences Inc., focusing on cell and gene immune-modulating therapies for cancer and infectious diseases. Prior to their current role, Francois held various leadership positions in companies such as Lineage Cell Therapeutics, OrthoCyte Corp, Rediens, Medtronic, Kyphon, Johnson and Johnson Regenerative Therapeutics, Depuy Biologics, DePuy Mitek, Ethicon, and Genzyme. Francois's extensive background in research and development in the biotechnology and medical device industry showcases their expertise in developing innovative solutions for various health conditions. Francois holds a PhD in Biology from Université Laval.